Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

Colon cancer, also known as colorectal cancer, is one of the most frequent and aggressive cancers. According to the WHO, it ...

The KRAS gene mutation, responsible for a quarter of all cancerous tumors, has met its match. Thanks to UCSF research, a tiny ...

An analysis of secondary endpoints showed that GLP-1 agonist users had a significantly lower risk of myocardial or cerebral ...

GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...

Immunotherapy uses the power of your immune system to fight your cancer. One type of immunotherapy is called an immune checkpoint inhibitor. Your immune system has built-in checkpoints that help it ...

Dr. Joshua Sabari sat down with Dr. Michael Cecchini to discuss advances in colorectal cancer management and key data ...

Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that ...

A woman who was diagnosed with stage 4 colon cancer has undergone 180 rounds of chemotherapy over nearly a decade — but says she's now on hospice care, as "no treatment options" were working anymore.

This thesis investigates less invasive treatments for large colon polyps and early-stage colon cancer. The focus on a new technique: the colonoscopy-assisted laparoscopic wedge resection (CAL-WR).

A man in his seventies developed fulminant capecitabine toxicity despite normal DPYD screening, revealing a rare variant that ...

This study of older, long-term cancer survivors found that chemotherapy was not a driver of late cardiovascular disease (CVD) ...